Liberty Capital Management, Inc. Abb Vie Inc. Transaction History

Liberty Capital Management, Inc.

$449 Million
Q3 2024

A detailed history of Liberty Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Liberty Capital Management, Inc. holds 39,148 shares of ABBV stock, worth $7.05 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

39,148

Previous 39,164 0.04%

Holding current value

$7.05 Million

Previous $6.72 Million 15.08%

% of portfolio

1.72%

Previous 1.6%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $2,621 - $3,189	-16 Reduced 0.04%	39,148 $7.73 Million
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $279,550 - $326,452	1,806 Added 4.83%	39,164 $6.72 Million
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $68,562 - $78,120	-429 Reduced 1.14%	37,358 $6.8 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $129,344 - $145,671	940 Added 2.55%	37,787 $5.86 Million
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $537,699 - $622,466	4,025 Added 12.26%	36,847 $5.49 Million
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $123,499 - $153,686	932 Added 2.92%	32,822 $4.42 Million
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $30,657 - $35,306	-212 Reduced 0.66%	31,890 $5.08 Million
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $62,654 - $75,139	453 Added 1.43%	32,102 $0
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $2.61 Million - $2.99 Million	19,429 Added 158.99%	31,649 $4.25 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $2.6 Million - $2.98 Million	-19,383 Reduced 61.33%	12,220 $1.64 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $104,591 - $132,969	-760 Reduced 2.35%	31,603 $4.84 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $225,289 - $279,521	1,707 Added 5.57%	32,363 $5.25 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $192,621 - $243,722	-1,793 Reduced 5.53%	30,656 $4.15 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $1,064 - $1,207	10 Added 0.03%	32,449 $3.5 Million
Q2 2021 Jul 16, 2021	SELL	$105.21 - $117.21 $53,972 - $60,128	-513 Reduced 1.56%	32,439 $3.65 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $254,215 - $279,860	2,485 Added 8.16%	32,952 $3.57 Million
Q4 2020 Jan 20, 2021	BUY	$80.49 - $108.67 $126,369 - $170,611	1,570 Added 5.43%	30,467 $3.27 Million
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $7,850 - $10,505	-107 Reduced 0.37%	28,897 $2.84 Million
Q1 2020 Apr 13, 2020	BUY	$64.5 - $97.79 $49,665 - $75,298	770 Added 2.73%	29,004 $2.21 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $3,606 - $4,512	50 Added 0.18%	28,234 $2.5 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $5,794 - $6,966	92 Added 0.33%	28,184 $2.13 Million
Q2 2019 Jul 15, 2019	SELL	$65.7 - $83.98 $7,949 - $10,161	-121 Reduced 0.43%	28,092 $2.04 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $17,819 - $20,972	-231 Reduced 0.81%	28,213 $2.27 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $50,135 - $61,830	-644 Reduced 2.21%	28,444 $2.62 Million
Q3 2018 Oct 26, 2018	BUY	$88.91 - $98.84 $43,210 - $48,036	486 Added 1.7%	29,088 $2.75 Million
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $34,834 - $41,217	388 Added 1.38%	28,602 $2.65 Million
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $9,937 - $13,306	108 Added 0.38%	28,214 $2.67 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $49,258 - $54,015	-550 Reduced 1.92%	28,106 $2.82 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $2 Million - $2.56 Million	28,656	28,656 $2.75 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Capital Management, Inc. with notifications on news.

Account

Liberty Capital Management, Inc. Abb Vie Inc. Transaction History